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ABSTRACT
Schistosomes are blood-dwelling helminth parasites that cause schistosomiasis, a debilitating 
disease resulting in inflammation and, in extreme cases, multiple organ damage. Major 
challenges to control the transmission persist and the discovery of protective antigens remains 
of critical importance for vaccine development. Rhesus macaques can self-cure following 
schistosome infection, generating antibodies that target proteins from the tegument, gut and 
esophagus, the last of which is the least investigated. We developed a dissection technique 
that permitted increased sensitivity in a comparative proteomics profiling of schistosome 
esophagus and gut. Proteome analysis of the male schistosomes esophagus identified 13 
proteins encoded by microexon genes (MEG), eleven of which were uniquely located in the 
esophageal glands. Based on this and transcriptome information, a QconCAT was designed 
for absolute quantification of selected targets. MEGs 12, 4.2, 4.1 and Venom allergen-like 
protein 7 were the mostly abundant, spanning over 245-6 million copies per cell, while 
aspartyl protease, palmitoyl thioesterase and a galactosyl transferase were present at <1 
million copies. Antigenic variation by alternative splicing of MEG proteins was confirmed 
together with a specialised machinery for protein glycosylation/secretion in the esophagus. 
Moreover, some gastrodermal secretions were highly enriched in the gut, while others were 
more uniformly distributed throughout the parasite, potentially indicating lysosomal activity. 
Collectively, our findings provide a more rational, better-oriented selection of schistosome 
vaccine candidates in the context of a proven model of protective immunity. 
Keywords:
Schistosoma mansoni; esophageal gland; gastrodermis; microexon genes; quantitative 
proteomics; QconCAT
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Introduction
Schistosomes are blood-dwelling helminth parasites responsible for a chronic and debilitating 
disease in individuals living in tropical and subtropical regions 1. At least 165 million people 
are estimated to be infected in Africa alone, largely based on detection of eggs in urine or 
faeces. However, the recent use of more sensitive diagnostics in areas of low transmission 
(<50% prevalence) indicates that cases of schistosomiasis may be underestimated by a factor 
of 1.5 to 6-fold when circulating cathodic antigen tests are compared to classical Kato-Katz 
technique 2. A single drug, Praziquantel, is currently available to treat infected individuals but 
has limitations, notably its lack of activity against juvenile worms 3. Chemotherapy invariably 
is started when the inflammatory responses against the eggs lodged in the host liver, 
intestines and bladder have already been established. In addition, data for 2016 suggest that 
annually the drug is only reaching ~36% of people needing treatment. In this situation, a 
protective vaccine to prevent infection remains of critical importance in the battle to combat 
schistosomiasis 4.
The rhesus macaque (Macaca mulatta) is unusual among the various vertebrate hosts that 
schistosomes can infect, in that it can eliminate adult worms. A mature Schistosoma mansoni 
population establishes with oviposition peaking at week 9 before a gradual decline between 
12 and 18 weeks 5. Recovery of surviving worms by perfusion of the hepatic portal system 
reveals that they have ceased feeding and are starving to death. Classical immunoproteomics 
(2D-PAGE and western blotting) indicated potential antibody targets in both surface 
tegument and secreted gut protein preparations 5. A more detailed investigation of S. 
japonicum infection in the Rhesus macaque has further illuminated the possible mechanisms 
that prevent blood feeding. The esophageal lumen, surrounded by the anterior and posterior 
esophageal glands, was identified as the primary site for interaction with a potent humoral 
immune response 6. Differential transcriptomics indicates that the gland secretions comprise a 
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cocktail of enzymes and a variety of proteins encoded by microexon genes (MEGs) 7,8. We 
have documented that initial processing of ingested blood occurs in the esophageal lumen by 
mixing with the gland secretions 9. Erythrocytes and platelets are lysed, while leucocytes are 
inactivated before they are propelled to the gut lumen where further digestion and absorption 
of nutrients take place 10. Notably, the rhesus macaque seems able to block this initial blood 
processing by disrupting the release of gland secretions, ultimately leading the parasites to 
starvation 6. To date, the function of these proteins has been inferred only from bioinformatic 
analyses of the encoding transcripts and their tissue pattern of expression 6–8. An important 
step in the characterisation of proteins released into the esophageal lumen as potential 
immune targets is to determine their profile and relative abundance.
There are multiple challenges associated with the proteomic characterisation of esophageal 
gland secretions from schistosomes. Perhaps, the most important is that both anterior and 
posterior esophageal glands represent a tiny percentage of the whole worm body 9. 
Consequently, constituents derived primarily from muscle tissues prevent identification of the 
unique set of gland products from whole worm extracts. Thus our recent investigation of the 
soluble protein composition of a S. mansoni preparation failed to detect any predicted gland 
constituents, attesting to their low abundance 11. In addition, the prediction of multiple splice 
variants for MEG proteins 12,13 indicates the need for a more refined experimental design for 
sample preparation, combined with the utilization of modern, fast and sensitive mass 
spectrometric platforms for protein identification and quantification.
Here we tackle these challenges using a dissection technique to specifically target and enrich 
the esophageal gland for proteomic characterisation. Absolute quantification of selected 
protein targets, using QconCAT technology 14,15, provided information on the abundance of 
gland constituents involved in blood processing. In addition, shotgun proteomics analysis 
confirmed that microexon genes expressed in the esophageal glands may be variably spliced. 
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Finally, a comparative analysis of the worm esophagus and posterior body (back end) served 
not only to highlight genuine gland products but also permitted the identification of proteins 
involved in nutrient acquisition in the lower alimentary tract. Overall, we believe our findings 
will provide the basis for a more rational and better-oriented selection of candidates of a 
vaccine against schistosome infection in the context of a proven model of protective 
immunity.
Experimental section
Ethical Statement
All procedures for maintenance of the S. mansoni life cycle and worm recovering were 
approved by the Ethics Committee on Animal Experimentation (Comissão de Ética no Uso 
de Animais – CEUA), Universidade Federal de Ouro Preto, protocol nº. 2011/55.
Worm recovery and dissection
Adult S. mansoni worms were obtained by portal perfusion of 45 day-infected mice using 10 
mM HEPES buffered RPMI-1640 medium, pH 7.4 (Sigma-Aldrich, USA), containing 4 
IU/ml of heparin. After extensive washes in pre-warmed medium (37 °C), parasites were 
instantly fixed in RNAlater® Solution (Invitrogen, UK) for protein stabilisation and stored at 
4 °C, as previously described 7. Briefly, adult male worms immersed in ice-cold RNAlater® 
were carefully held and dissected using fine curved tweezers (Ideal Tek, Chiasso, 
Switzerland) and Vannas scissors (John Weiss, Milton Keynes, UK), under a 
stereomicroscope at x35 magnification. First, the oral sucker was removed by an incision at 
its posterior, at the very beginning of the esophagus. Next, a second cut along the line of the 
transverse gut released the esophageal fragment (ESO). The back end (BE) comprising the 
posterior third of the male body was excised for comparative analysis. Dissected fragments 
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were preserved in RNAlater® Solution at 4 °C until sample preparation, following the 
manufacturer’s instruction. The detailed and illustrated dissection procedure is uploaded at 
protocols.io repository 16 (https://www.protocols.io/) and accessible via DOI 
dx.doi.org/10.17504/protocols.io.tq2emye. Biological replicates obtained from independent 
mouse infection, perfusion and worm dissection procedures provided material for individual 
shotgun and targeted proteomic analyses.
Sample preparation and in-solution digestion
ESO and BE fragments were washed twice in 1 mL of ice-cold PBS, pH 7.4, to remove 
RNAlater® Solution, as recommended by the manufacturer. Samples were sonicated in ice 
bath for 5 cycles of 10 second pulses at 30% amplitude (Sonics Vibra Cell™; Jencons 
Scientific Ltd, UK), with 50 seconds intervals. Total protein concentration was determined 
using a Coomassie Plus (Bradford) assay kit (Thermo Scientific, UK) by interpolation from a 
BSA standard curve, according to the manufacturer’s instructions.
Sample aliquots equivalent to 20 µg of protein were processed through in-solution digestion 
protocol, essentially as described elsewhere 17. Briefly, the aliquots were transferred to 
LoBind tubes (Eppendorf, USA) and made up to 100 µL by the addition of 25 mM 
ammonium bicarbonate (AMBIC). Protein denaturation was induced by the addition of 20 µL 
of RapiGest SF 1% w/v (Waters, UK) and heating at 80 °C for 10 min. Next, sample volume 
was adjusted to 180 µL with AMBIC before reduction (addition of 10 µL 60 mM 
dithiothreitol, 60 °C for 10 min) and alkylation (addition of 10 µL 180 mM iodoacetamide 
and incubation at room temperature for 30 min). MS-grade trypsin (Promega) was added at 
an enzyme:substrate ratio of 1:50 and digestion allowed to occur at 37 °C for 16 h. 
Trypsinolysis was terminated by addition of 1.5 µL trifluoroacetic acid. Acidified samples 
(pH<2) were then incubated at 37 °C for 45 min to precipitate RapiGest SF, which was later 
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7
removed by centrifugation at 13,000g for 15 min at 7 °C. Supernatant was recovered for LC-
MS analysis. 
nLC-ESI-MS/MS analysis of ESO vs BE region
ESO and BE digests were analysed by a discovery-based proteomics approach using either a 
Q Exactive HF™ hybrid quadrupole-orbitrap (Thermo Scientific, Germany) or an Orbitrap 
Fusion™ Tribrid™ mass spectrometer (Thermo Scientific, Germany). Both instruments were 
coupled to Dionex™ UltiMate™ 3000 UHPLC system (Thermo Scientific, Germany) with 
the same column specifications. Briefly, 700 ng of digested samples were resolved over a 90- 
or 95-min gradient and analysed in positive mode using the Q Exactive HF and Orbitrap 
Fusion instruments, respectively. Spectral acquisition on the Q Exactive HF was performed 
using Top16 data-dependent acquisition (DDA) whereas Orbitrap Fusion operated in 
TopSpeed DDA mode with a 3-second cycle. In the latter platform, samples were analysed 
using CID and HCD activation capabilities of the instrument, and product ions were detected 
using the Ion Trap at rapid scan rate. Expanded LC-MS methods including a geLC-MS/MS 
analysis using a Q Exactive mass spectrometer (Thermo Scientific, Germany) for 
construction of a spectral library are available in the Supplementary Material S1. 
Database search and label-free quantification
De novo sequencing-assisted database searching 18 was performed using PEAKS Studio v8.5 
(Bioinformatics Solutions Inc, Canada). Firstly, spectral data were searched against S. 
mansoni sequences deposited at GeneDB.org (downloaded at 17/10/2017) supplemented with 
protein sequences of esophageal hydrolases detected in a previous RNAseq experiment 7 
(10,875 sequences; 5,942,443 residues). Esophageal MEG proteins were individually 
searched using a database composed of the sequences deposited in GeneDB and NCBI plus 
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putative alternative spliced variants generated in silico by combinatorial exon permutation 
(2,269 sequences; 223,997 residues). Precursors and product ion mass error tolerances were 
set respectively to 15 ppm and 0.02 Da, for the Q Exactive HF, or 10 ppm and 0.35 Da, for 
the Fusion instrument. Enzyme specificity was set to trypsin (P1 = K/R, except if P1’= P) 
allowing up to one missed cleavage site. Cysteine carbamidomethylation and dynamic 
methionine oxidation were set as peptide modifications. The quality threshold for Peptide-
spectral match (PSM) was adjusted to keep the false discovery rate (FDR) ≤0.01.
Relative label-free quantification for comparative ESO vs BE analysis was performed using 
Peaks Q enabling the exclusion of peptides with both modified and unmodified forms. 
Differentially abundant proteins with Benjamin–Hochberg adjusted p-values ≤0.01, fold 
difference ≥1.5 and at least two unique peptides comprised the subset of ESO- or BE-
enriched components.
Gene ontology and functional categorisation
Differentially abundant proteins were subjected to gene ontology analysis using a PRO trial 
licenced Blast2GO v5 software 19. Gene Ontology (GO) terms were mapped and the Fisher’s 
Exact Test (FDR ≤0.05) assessed the enrichment of specific biological processes, molecular 
functions and cellular components amongst the proteins with higher relative abundances in 
the ESO compared to BE. Functional enrichment analysis on STRING v11 20 provided 
KEGG pathways, keywords and GO terms over-represented in the list of differentially 
abundant proteins. Additional categorisation of cellular markers, namely the glycosyl 
transferases and gastrodermis secretion, was performed essentially as described elsewhere 
7,21.
QconCAT design, expression and purification
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Based on state of the art QconCAT technology 14,15 , an EsoCAT construct was designed by 
concatenating proteotypic peptides to obtain an artificial protein that served as the internal 
standard for simultaneous quantification of multiple analytes. The targets selected for 
absolute quantification comprised nine proteins with specific expression in the esophageal 
glands, previously validated by whole-mount in situ hybridization and confocal microscopy 
7,9, and detected by mass spectrometry.
Fifteen proteotypic peptides were selected from our in-house spectral library. Two additional 
peptide sequences were chosen based on their putative detectability, as predicted by the 
CONSeQuence algorithm 22, and two N-terminal variant tryptic peptides were selected to 
investigate co-occurring MEG-12 isoforms (Supplementary Material S2). Uniqueness of 
proteotypic peptides was ascertained against the Mus musculus (UniProt UP000000589; 
60,177 sequences and 27,265,929 residues) and Escherichia coli BL21-DE3 (UniProt 
UP000002032; 4,156 sequences and 1,298,178 residues) proteomes, and GPM collection of 
common contaminants cRAP (116 sequences and 38,459 residues).
A minimum of two proteotypic peptides was selected for each target protein, with the 
exception of MEG-4.2 for which only one tryptic peptide had been identified during our 
spectral library construction. Moreover, sequences consisting of three amino acids found 
naturally flanking the proteotypic peptides in the endogenous target proteins were preserved 
in the EsoCAT construct to provide conditions for both analyte and internal standard to be 
evenly digested, as described elsewhere 23. The complete EsoCAT primary structure 
comprised a N-terminal initiator methionine followed by the glufibrinopeptide B 
(EGVNDNEEGFFSAR), and a C-terminal hexahistidine tag (Supplementary Material S2).
For heterologous expression of EsoCAT, the synthetic gene was ligated into a pET21a 
plasmid vector (Eurofins Genomics, Germany) and transformed into BL21 (λDE3) competent 
E. coli cells. EsoCAT expression was induced in the presence of 1 mM isopropyl β-D-1-
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thiogalactopyranoside (IPTG) in minimal culture media containing 13C6 labelled lysine and 
arginine, as described elsewhere 24. After 3.5 hours of induction, E. coli cells were collected 
by centrifugation (1,450 g, 15 min, 4 °C), resuspended in 50 mM AMBIC, pH 8.0, containing 
25 U/mL benzonase nuclease (Novagen), 1x Complete EDTA-free protease inhibitor tablet 
(Roche), and sonicated in an ice bath using 10 second pulses at 30% amplitude, with 50 
second intervals, until 130 joules was reached. After centrifuging the homogenate at 6,000 g, 
7 min, 7 °C, the EsoCAT protein present in the insoluble inclusion body pellets was 
solubilised in Buffer A (20 mM NaPO4, 0.5 M NaCl, 10 mM imidazole, 6 M guanidine 
hydrochloride, pH 7.4) and filtered using a 1.2 µm syringe filter.
EsoCAT purification was carried out using an AKTA start chromatography system (GE 
Healthcare) equipped with a 1 mL HisTrap™ HP column (GE Healthcare). System 
conditioning and washing were performed using Buffer A before bound proteins were eluted 
over a 20 min gradient of 0-100% Buffer B (20 mM NaPO4, 0.5 M NaCl, 500 mM imidazole, 
6 M guanidine hydrochloride, pH 7.4), at a flow rate of 1 mL∙min-1. Eluted fractions 
containing EsoCAT were pooled and dialysed against 50 mM AMBIC containing 1 mM 
dithiothreitol. Purified EsoCAT preparation was supplemented with 0.1% (w/v) RapiGest SF 
(Waters) and aliquoted for storage at -20 °C in LoBind tubes (Eppendorf). Immediately 
before use, EsoCAT was thawed then heated to 60 °C in the presence of 3 mM dithiothreitol 
for protein reduction, thus preventing aggregate formation and precipitation.
In-solution co-digestion with EsoCAT internal standard
Absolute quantification required the co-digestion of the proteome of interest and the 
QconCAT internal standard. Four replicates of a master mixture were prepared by spiking an 
estimated concentration of purified EsoCAT protein into 20 µg of the ESO proteome. The 
master mixtures were subjected to our standard in-solution digestion protocol in the presence 
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of 100 fmol glufibrinopeptide B (Glufib B >98% purity; Severn Biotech) enabling the 
accurate quantification of the EsoCAT protein. In parallel, 20 μg digests containing only the 
ESO proteome were produced and used for serial dilution of the master mix by factors of 
1:10 and 1:100. This ensured the EsoCAT internal standard spanned a concentration range of 
two orders of magnitude (~0.15-150 fmol/μg of ESO proteome). LoBind tubes were used in 
all steps of this experiment.
Absolute quantification by SRM-MS
Absolute quantification was performed on a nanoACQUITY UPLC™ system coupled to a 
Xevo TQS triple quadrupole mass spectrometer (Waters) set to Selected Reaction Monitoring 
(SRM) acquisition mode, with Q1 and Q3 operating at unit mass resolution. Up to one 
microgram of digested samples was loaded onto a Symmetry C18 trap column (5 µm, 180 µm 
x 20 mm; Waters) and washed for 3 min, at a flow rate of 5 µL∙min-1, with 0.1% (v/v) formic 
acid in water. Peptides were resolved on the analytical column HSS T3 nanoACQUITY C18 
(1.8 µm, 75 µm x 150 mm; Waters) over a 90 min linear gradient of 3-40% (v/v) MeCN in 
0.1% (v/v) formic acid, at a constant flow of 300 nl∙min-1, at 35 °C. SRM acquisition was 
scheduled with 4 min windows and dwell times automatically adjusted to achieve ≥12 
sampling points per peak. Three to four product ions with highest relative intensity in 
experimental MS/MS spectra and m/z > precursor ion were selected to compose the list of 
transitions. 
Data analysis of QconCAT assay
Quantification of endogenous and surrogate peptides was performed using Skyline v4.2 25 by 
integrating extracted ion chromatograms for transitions monitored in light and heavy 
channels, respectively (Supplementary Material S2). An equivalent number of transitions 
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with random mass shifts (decoys) was also monitored allowing peak validation and FDR 
calculation by mProphet 26. The concentration of labelled peptides was firstly assessed based 
on the reference Glufib B peptide. Analyte quantification was finally achieved using the light 
to heavy ratios observed in the isotopic dilution that fulfilled the following criteria: (i) closest 
1:1 ratio (never exceeding 10x fold) between the internal standard and endogenous analyte 
that exhibited a (ii) mProphet’s FDR ≤ 0.05 score in at least three out of four replicates.
To classify the performance of proteotypic peptides monitored by the SRM quantitative 
assay, we adopted the terminology described by Brownridge et al (2011) 27. Accordingly, 
peptides were classified as Type ‘A’ when EsoCAT standard and endogenous analyte 
delivered high quality quantification data (‘S+/A+’ or ‘standard positive, analyte positive’), 
Type ‘B’ when solely EsoCAT internal standard (‘S+/A-’) was observed, or Type ‘C’ when 
peptides could not be observed in either heavy or light channels (‘S-/A-’). We refined this 
classification system by incorporating mProphet scores into the results. This divided Type 
‘A’ category into two further subgroups: Type ‘A1’ peptides successfully passed mProphet’s 
5% FDR threshold and were used for protein quantification, whereas Type ‘A2’ peptides 
failed to give a clearer signal compared to decoy transitions (mProphet’s FDR >0.05) and 
were removed.
Results
Mass spectrometry analyses of ESO detect predicted esophageal gland proteins and sequence 
variation
For the first time we were able to identify predicted esophageal gland proteins using a mass 
spectrometry-based approach on the ESO-enriched preparation. Detection of the group of 
MEG-encoded proteins, known to be specifically expressed in the gland cells 7,28,29, 
confirmed the successful combination of shotgun proteomics and microdissection procedures. 
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Database search against deposited MEG-encoded sequences and alternative spliced variants 
generated by in silico exon permutation allowed the identification and study of MEG 
isoforms expressed in the esophageal gland. In parallel, database interrogation against S. 
mansoni protein sequences deposited in GeneDB resulted in a list of 4,024 proteins identified 
at ≤1% FDR. This was later reduced to 3,019 identities confidently assigned to at least two 
unique peptides. 
Compositional analyses revealed that ESO and BE preparations share over 90% of the 
proteins confidently detected, whilst 141 and 54 proteins were exclusive to ESO and BE 
samples, respectively (Figure 1A). Among the proteins exclusively detected in the ESO 
sample, ten MEG proteins (MEG-3.4, MEG-4.1, MEG-4.2, MEG-5, MEG-8.1, MEG-8.2, 
MEG-8.4, MEG-14, MEG-15 and MEG-24) were confidently identified in this proteomic 
analysis, with ≥2 two PSM per protein at a false discovery rate ≤1%. Additionally, MEG-
26.3, MEG-16 and MEG-12 were detected using less stringent filter criteria (1 PSM at ≤1% 
FDR). Median peptide intensity values of unique peptides indicated that eleven of these MEG 
proteins are uniquely present in the worms’ esophagus (Figure 1B; Supplementary Material 
S3). The remaining two namely MEG-5, a protein assigned to the tegument 12, and MEG-24 
were detected at similar levels in the ESO and BE preparations normalised by their total 
protein content. 
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A second protein family investigated comprised the Venom Allergen-Like (VAL) proteins 
since VAL-7 was the second gland-specific constituent discovered 28. Our data confirmed 
that VALs 7 and 13 were highly enriched in the ESO fraction compared to BE (Figure 1B), 
whereas VALs 11, 12 and 16 had similar intensities in the two preparations, and VAL-6 
found at higher levels in the BE.
Notably, our analysis produced not only the first MS-based detection of esophageal MEG 
proteins but also delivered evidence of co-occurring isoforms of these gland secretions. 
Sequence variations detected from the pool of worms includes alternative spliced sequences, 
residue substitution and deletion. For instance, in comparison to the full-length of MEG-4.1 
(GenBank accession AAA29855) we observed two amino acid substitutions, K57E and I213F 
(Figure 2A), that matched other deposited transcript sequences (e.g. GenBank accession 
AAP13803.1 and RefSeq XM_018793269.1). Moreover, we gathered evidence for the co-
occurrence of MEG-4.1 isoforms resulting from alternative splicing. The peptide 
‘EYIEDKNVDIR’ present in the full-length sequence of MEG-4.1 is formed over an exon-
exon junction so that five N-terminal amino acids are encoded by exon 8, whereas the 
following residues are encoded by exon 10 (27 bp). Hence, skipping exon 10 results in 
Figure 1. Composite analyses of ESO 
and BE samples and differential 
abundance of esophageal signatures. 
(A) Venn diagram indicating over 90% 
commonalities between the proteins 
confidently identified (≥2 unique 
peptides; FDR ≤0.01 FDR) in the 
samples. A fraction of 141 proteins 
were detected only in the esophageal 
region (ESO) whilst 54 were present 
uniquely in the back end (BE) of adult 
male worms. (B) Abundance of unique 
peptides indicated that 11 out of 13 
MEG are among the exclusively 
expressed in the schistosome 
esophagus, similarly VAL-7.
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ligation between exons 8/11 and omission of the 9-mer sequence ‘KNVDIRIIG’ 
(K62_G70del), ultimately creating the new detectable tryptic product ‘EYIEDNKK’ (Figure 
2A). It is noteworthy that exon 9 is rarely incorporated into MEG-4.1 transcripts and its 
asymmetrical structure of 89 bp would produce an incomplete protein by disrupting the open 
reading frame.
In a second case, the deletion of a glutamine residue (Q67) in MEG-4.2 (Smp_085840.1) also 
resulted in an alternative detectable proteotypic peptide for this esophageal protein. The 
peptide ‘QLEEEQNPFHK’ is formed over the junction of exons 6/7 so that the second 
glutamine of the sequence overlaps a splice site (Figure 2B). The alternative sequence, 
‘QLEEENPFHK’, is obtained via an alternative splice site at the 3’-end of exon 6 that 
changes the exon length from 21 to 18 bp, excluding the glutamine codon. Finally, peptide 
identifications of MEG-14 matched alternative sequences shared by several known isoforms 
Figure 2. Coverage of MEG-4.1 and 4.2 isoforms by shotgun proteomics. (A) Full length 
sequence of MEG-4.1 (AAA29855) highlighting the mechanism of sequence variation of the 
detected isoforms. Amino acids encoded by exon 10 (red area) are deleted and direct ligation of 
exons 8 / 11 occurs (green area). Additionally, two residue substitutions (K57E and I213F) are 
indicated in the boxes. Residues in orange are predicted sites of O-glycosylation. Versions of MEG-
4.1 incorporating exon 9 are rare and incomplete. The hashed line above the protein sequence 
indicates the tandemly repeated region. (B) MEG-4.2 protein sequence (Smp_085840.1) with a 
residue encoded by an alternative splicing site (Q67) highlighted in red. The alternative sequence 
with Q67del is symbolised by the box with “X”. Peptide matches (FDR ≤0.01) are indicated by blue 
(≥2 PSM) and yellow (1 PSM) bars below the sequences.
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produced by alternative splicing 13. However, none of the five peptides detected are self-
excluding, hence a unique isoform cannot be identified unambiguously. Instead, we observed 
that the peptide sequences are sometimes present in two, or in up to seven different MEG-14 
variants (Supplementary Material S3). 
QconCAT proteomics allows the abundance of gland secreted proteins to be determined
We employed QconCAT-based quantification to capture the abundance of nine specific gland 
antigens in the ESO proteome. Seventeen out of 21 precursor ions monitored by SRM for 
absolute quantification were classified as Type ‘A1’ peptides (i.e. both analyte and surrogate 
peptides detected at mProphet FDR ≤ 0.05), thus being suitable for quantification 
(Supplementary Material S4). After removal of low scoring peptides (mProphet FDR >0.05), 
MEG-4.1, MEG-8.2, MEG-15, VAL-7, aspartyl protease and palmitoyl thioesterase could be 
quantified by two of their proteotyptic peptides and three other proteins (MEG-4.2, MEG-12 
and -1,3-GalTase) by a single peptide standard each. 
Using a mass-to-mass unit (ng/µg) the nine quantified proteins amounted to only ~0.5% of 
the total protein found in the male worms’ esophagus (0.5 ± 0.17 μg per ESO fragment; 
Supplementary Material S4). However, since only 750 and 1,000 cells comprise the anterior 
and posterior glands 9 respectively, it is reasonable to expect that the gland products would 
not dominate an esophageal homogenate. Therefore, we estimated the number of protein 
copies per cell (cpc) as a better representation of our quantitative data since it normalised 
protein abundance to the number of producing cells (Figure 3).
When the data are viewed in this way, MEG-12, the only selected target demonstrated as 
expressed in the anterior gland, showed extraordinary abundance with over 245 million cpc, 
likely the integral of production and externalisation. VAL-7, MEG-4.2 and MEG-4.1 were 
also highly abundant with between 12.2-4.5 million cpc (Supplementary Material S4). The 
Figure 3. Absolute quantification of 
esophageal gland proteins. Protein copies 
normalised by the number of cells comprising 
the anterior and posterior esophageal glands in 
S. mansoni adult male worms, according to Li 
et al (2013). MEG-12, the only selected target 
demonstrated as being expressed in the 
anterior gland showed the highest abundance 
(~245 million cpc), followed by VAL-7 and 
MEGs-4.1 and 4.2. The EsoCAT construct 
allowed the quantification of MEG-4.1 via one 
peptide canonically expressed in the isoforms 
detected in this study and a second proteotypic 
peptide exclusive to a isoform subset (hashed 
bar).
Page 16 of 39
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
17
remaining predicted secreted proteins, namely MEG-15, MEG-8,2, palmitoyl thioesterase and 
aspartyl protease presented lower levels of 0.5-1 million cpc, whilst the endoplasmic protein 
-1,3-GalTase showed the lowest cellular content of ~380 thousand cpc.
Importantly, the knowledge about isoforms of MEG-4 family members must be considered in 
the QconCAT analysis. The two proteotypic peptides of MEG-4.1 included in the EsoCAT 
allowed the quantification of specific isoform subsets. Thus, MEG-4.1 variants containing an 
isoleucine rather than a phenylalanine residue at position 213 accounted for 71% of all copies 
detected using the second peptide, QINDGTSDKPK, conserved among known alternative 
sequences (Figure 3; MEG-4.1 solid and hashed bar). In the case of MEG-4.2, we only 
present the absolute quantification of the full length containing the QLEEEQNPFHK peptide 
- without the glutamine deletion. The occurrence of putative splicing variants of MEG-12 was 
not confirmed by the second peptide inserted in the EsoCAT construct. More specifically, we 
detected and quantified ENYEQQLQQPK (Smp_152630.1; both internal standard and 
endogenous analyte present) but not the FHIVFFCGENYEQQLQQPK (Smp_152630.2; only 
internal standard present), suggesting that the putative splicing variant Smp_152630.2 lies 
below the instrumental limit of detection (Figure 4).
Figure 3. Absolute quantification of 
esophageal gland proteins. Protein copies 
normalised by the number of cells comprising 
the anterior and posterior esophageal glands in 
S. mansoni adult male worms, according to Li 
et al (2013). MEG-12, the only selected target 
demonstrated as being expressed in the 
anterior gland showed the highest abundance 
(~245 million cpc), followed by VAL-7 and 
MEGs-4.1 and 4.2. The EsoCAT construct 
allowed the quantification of MEG-4.1 via one 
peptide canonically expressed in the isoforms 
detected in this study and a second proteotypic 
peptide exclusive to an isoform subset (hashed 
bar).
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GO analyses suggest distinctive molecular functions in the worm esophagus
Next, we performed an ESO vs BE comparative analysis using label-free relative 
quantification. A high similarity between the preparations was observed in the Orbitrap 
Figure 4. Proteotypic peptides monitored for MEG-12 quantification. (A) Extracted ion 
chromatogram of transitions monitored for FHIVFFCGENYEQQLQQPK peptide indicated that the 
Smp_152630.2 isoform is below the limit of detection. (B) Conversely, at the same spiking levels 
of ENYEQQLQQPK internal standard the endogenous analyte derived from Smp_152630.1 isoform 
is detected.
Figure 5. Shotgun quantitative 
analysis of ESO and BE samples. 
Compositional differences unveiled 
by label free relative quantification of 
the data acquired using Orbitrap 
Fusion (A) and Q Exactive HF (B) 
indicating, respectively, 442 and 396 
differentially abundant proteins 
(adjusted p-value ≤0.01, ≥1.5-fold 
difference, ≥2 unique peptides). 
Pearson’s correlation indicates high 
similarity between the two 
preparations (R2 >0.92).
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Fusion and Q Exactive HF analysis (Pearson’ r > 0.9; Figures 5A-B). Nevertheless, a total of 
669 proteins were found differentially abundant in the two platforms together (adjusted p-
values ≤0.01, fold difference ≥1.5, ≥2 unique peptides; Supplementary Table S1A-B). 
Functional analysis using STRING database indicated the enrichment of a cluster of 
esophageal proteins involved in glycerophospholipid and sphingolipid metabolism, and 
lysosomal lecithin:cholesterol acyltransferases among the differentially abundant proteins 
(Figure 6; right). On other hand, a remarkable enrichment of proteases in the BE was 
indicated by the overrepresentation of cysteine/papain-like peptidases metalloproteases and 
C1A peptidases (Figure 6; left). The lysosomal pathway and a cluster of proteases/C1A 
peptidases displayed a heterogenous composition with molecules differentially abundant in 
BE and ESO (Figure 6, hashed markers) indicating site-specific activities. 
Figure 6. STRING functional analysis of differentially abundant proteins. INTERPRO domains 
associated with proteolytic activity are significantly overrepresented among proteins enriched in the 
BE (red circles, left). Two clusters of proteins associated with the glycerophospholipid/sphingolipid 
and lecithin:cholesterol metabolism were detected in the ESO component (purple; right). 
Constituents of lysosome pathway and a set of proteases/peptidases C1A were enriched in both 
samples suggesting site-specific activities (hashed circles; centre).
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Next, a GO enrichment analysis was performed by direct comparison of the 359 proteins 
enriched in the male worm’s ESO versus the 330 more abundant in the BE. Twenty-three 
over-represented biological processes (FDR ≤ 0.05) could be abridged to seven GO terms, 
representing protein biosynthesis and glycosylation, vesicle-mediated transport - including 
Golgi vesicles, oxidation-reduction processes and drug metabolism. Molecular functions and 
cellular components supported the presence of hexosyltransferases, membrane complexes, 
including those in endoplasmic reticulum/Golgi and mitochondrion, as well the 
oxidoreductase complex (Figure 7). 
 A closer look at the total of 25 quantified glycosyl transferases showed a greater abundance 
in the esophageal region, by a median factor of 1.8-fold (Figure 8; Supplementary Table  
S1C). Notably, 16 out of 18 differentially abundant glycosyl transferases were enriched in the 
ESO sample. Seven of these are dolichol lipid-linked endoplasmic reticulum transferases. 
Five enzymes with transferase activities spanning galactosyl (Smp_151220), GalNAc 
(Smp_057620, Smp_005500) and mannosyl (Smp_042790, Smp_177080, Smp_102430) 
glycans were also significantly enriched, as were two endoplasmic reticulum glucosidases 
(alpha-mannosidase, Smp_143430; mannosyl oligosaccharide glucosidase, Smp_024580). 
Figure 7. GO terms over-represented in the ESO compared to BE. Direct comparison of proteins 
differentially abundant in the ESO vs BE revealed that GO terms associated with bioenergetics (oxidative 
phosphorylation), biosynthetic processes (protein biosynthesis and glycosylation) and vesicle-mediated 
transport are over-represented in the esophagus (FDR≤0.05).
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Together, these findings indicate a distinct machinery for production of specialized glycans in 
the esophageal glands.
Figure 8. Differential abundance of glycosyl transferases in the ESO and BE samples. Diagram 
showing an enrichment of proteins related to glycosylation processes in the schistosome esophagus 
(right side). The shaded area indicates the equivalence range (<1.5-fold difference). Proteins are 
rank ordered according to their average Log2 fold ESO/BE. Differential expression supported by 
statistical analysis (adjusted p-value ≤0.01) are indicated by solid symbols.
Page 21 of 39
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
22
STRING analysis of proteins differentially abundant in the ESO revealed a network 
connecting protein biosynthesis, glycosylation and secretory pathways (Figure 9A). Proteins 
involved in a variety of vesicle-trafficking processes featured prominently in the parasite 
esophagus. Those included a tetraspanin CD63 receptor (Smp_041460; 4.6x-fold difference), 
a non-tegument annexin (Smp_155580; 37x-fold), charged multivesicular body protein 
(Smp_079000; 1.5x-fold) and proteins involved in sphingolipid biosynthesis (e.g. longevity 
assurance gene 1, Smp_147460, 2.4x-fold; ceramidase, Smp_122050, 26x-fold; fatty acid 
desaturase 2, Smp_132740, 8.7x-fold; ormdl protein, Smp_210370, 1.6x-fold). The 
enrichment of signal recognition particles (e.g. SRP-14, 19, 68, 72; average 1.7x-fold 
Figure 9. Network featuring protein biosynthesis, glycosylation and secretion in the 
schistosome esophagus. (A) Diagram highlighting the clustering of protein biosynthesis, 
glycosylation and secretory pathways (coloured circles) among proteins differentially abundant in 
the ESO. Blank circles are mostly related to bioenergetics and small molecules metabolism. (B) 
Normalised distribution shows an average 2-fold increase on the abundance of proteins associated 
to vesicle transport and protein secretion. Best-fit values and 95% confidence interval (CI) were 
calculated using Lorentzian function.
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difference) and signal peptidases (Smp_031730, Smp_024390.2 and Smp_024390.3; average 
1.7x-fold) reinforced that the classical secretory pathway is operational in the esophagus. In 
addition, a number of differentially abundant proteins related to SEC-translocation channels 
(e.g. SECs23, 63, 24a, 16a; average 2.1x-fold difference), Coatomer subunits for COPII- and 
COPI-vesicle coat (Smp_015090, Smp_031860, Smp_245450 and Smp_124430; average 
1.8x-fold difference), translocon-associated proteins (Smp_075870.1, Smp_071600, 
Smp_074700; average 2.1x-fold difference) and ARF GTPases (Smp_086900, Smp_179610; 
average 1.8x-fold difference) provides evidence for formation of endoplasmic 
reticulum/Golgi secretory vesicles. Althogether, the abundance of all those proteins was 
skewed by a factor of 2-fold towards the parasite esophagus (Figure 9B). Of note, similarities 
between the esophageal gland and tegument secretion processes led us to inspected our data 
for 36 proposed tegument signatures 7. Their average ESO/BE fold difference was 0.95 
indicating an even distribution over the worm surface thus reinforcing that the enrichment we 
observed in the ESO preparation is a true reflection of differences in protein composition.
Gastrodermal secretions are also pinpointed by the comparative analysis
The results of our ESO vs BE label-free quantification provided the expression pattern of 
proteins related to digestive processes over the extent of the esophagus and lower 
gastrodermis. Classical gut-associated proteins previously identified in the worm’s vomitus 21 
were confirmed as highly enriched in the BE sample (Figure 10; Supplementary Table S1D), 
these included cathepsin B1 (Sm31 - Smp_103610; Smp_067060), cathepsin S 
(Smp_139240), asparaginyl endopeptidase (Sm32 - Smp_075800), lysosome-associated 
membrane glycoprotein (Smp_162770) and saposin B (Smp_014570).
On the other hand, we unexpectedly observed that a set of proteins thus far attributed to the 
gastrodermis on the basis of vomitus analysis were equally detected in the ESO and BE 
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samples. For instance, Acyl-CoA thioesterase, β-D-xylosidase, DJ-1/PARK7-like protease, 
Nieman Pick C2 (NPC2), vesicle associated membrane protein, lysosomal Pro X 
carboxypeptidases (Smp_002600 and Smp_071610) and two saposins (Smp_130100 and 
Smp_016490) did not show statistical differences in relative quantification between the ESO 
and BE samples. Furthermore, some vomitus proteins were differentially expressed in the BE 
sample but with only a modest enrichment (≤ 2-fold) compared to the ESO; these included 
ferritin, apoferritin, α2-macroglobulin, cathepsins C/D, ester hydrolase, serpin and a saposin 
(Smp_194910). It is noteworthy to mention that inaccurate dissection could lead to 
contamination of ESO fragments with highly abundant gastrodermis components impairing 
the identification of sample-specific proteins. However, we did not observe any bias 
suggesting that the MS-signal intensity was directly linked to the presence or absence of 
differential expression between ESO and BE (Supplementary Material S5). 
In addition to the gut-secreted proteins described by Hall et al. (2011), we detected other 
molecules potentially related to gastrodermal functions, such as a serine carboxypeptidase 
(Smp_172590) 22x-fold more abundant in the BE sample. An additional saposin B 
Figure 10. Differential abundance of putative gut secretions in the ESO and BE samples. 
Diagram showing a biased expression (median difference of 1.7x-fold) of gastrodermal markers 
towards the schistosome back end (left side). Intriguingly, a group of proteins so far attributed to 
the gastrodermis exhibited an even distribution between the ESO and BE samples (shaded area). 
Proteins are rank ordered according to their average Log2 fold ESO/BE. Differential expression 
supported by statistical analysis (adjusted p-value ≤0.01) are indicated by solid symbols.
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(Smp_105420; ~5x-fold difference) was also detected significantly enriched in the BE 
supported by only one unique peptide (Supplementary Material S5). Furthermore, the 
expression pattern of cathepsins F/L (Smp_034410, Smp_139160 and Smp_210500), also 
known as SmCL1, SmCL2, SmCL3, revealed that only the second confidently exhibits higher 
abundance in the BE sample.
Discussion
In this work we used quantitative proteomics to assess the composition of the S. mansoni 
alimentary tract.  This investigation allowed us to designate proteins functionally associated 
with the anterior and lower regions of the parasite’s alimentary tract, namely the esophagus 
and gastrodermis, represented by the ESO and BE preparations, respectively. The 
combination of a microdissection procedure and relative quantification of these preparations 
has permitted the correct assignment of signature proteins to their specific sites of expression. 
Particularly, proteins encoded by microexon genes known to be expressed in the anterior and 
posterior esophageal glands were detected by proteomics for the first time, expanding our 
knowledge of these tissues, thus far limited to transcriptomic analysis 7,8. This enabled us to 
acquire further information on gland constituents by absolute quantification, using QconCAT 
methodology. Lastly, ESO vs BE comparisons also provided an informative update of the 
repertoire of S. mansoni gastrodermal markers.
The efficiency of our dissection method for enrichment was firstly confirmed by the ability to 
detected specific esophageal MEG proteins (e.g. MEG-4.1) and VAL-7 in the ESO sample, 
since evidences gathered from independent molecular analysis such as whole-mount in situ 
hybridisation 28,29, confocal microscopy and RNA-seq 7 verified their specific expression and 
location in the esophageal gland tissues. The successful detection of the putative esophageal 
gland secretions can be attributed to substantial enrichment achieved through dissection, 
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followed by sensitive high-resolution mass spectrometry. Our previous attempts using 2D-
PAGE of the whole male worm heads followed by mass spectrometry, failed to detect a 
single genuine gland secretion 9. Instead, house-keeping proteins and those massively 
abundant in the major schistosome tissues (i.e. sucker and body wall muscles, and 
parenchyma) dominated the preparation. Similarly, shotgun proteomics of soluble parasite 
components using modern LC-MS instrumentation was also inefficient for the detection of 
such low abundance antigens 11. 
Although the exact functions of MEG proteins have yet to be demonstrated, most display 
peculiar structural elements and low homology outside the Schistosoma genus, suggesting 
they may possess unique roles in worm physiology. The unusual structure of these genes, 
mainly composed of short (<36bp) and symmetric exons (multiple of three bases), allows the 
generation of several variants by alternative splicing events without disrupting the reading 
frame 30, thus preserving the main protein backbone. In fact, the expression of multiple MEG 
isoforms was confirmed in our data. It has been hypothesised that these variation events 
could be linked to evasion mechanisms deployed under a selective pressure created by the 
host immune system 12. More specifically, the amino acid substitution observed for MEGs 4.1 
and 4.2 corroborate the previously reported high synonymous and nonsynonymous 
substitution rates (dN/dS) in schistosome microexon genes 31. It is noteworthy that high 
dN/dS rates have been reported for antigens constantly exposed at host-parasite interfaces 
(e.g. gut secretions and tegument exposed proteins), including the vaccine candidates Sm29 
and Tetraspanin-2 (Sm-TSP2), and VAL proteins 31. This could in fact anticipate that 
esophageal MEGs are targeted by the host immune response and might constitute a set of 
new vaccine candidates. However, we must bear in mind that in those cases, sequence 
variation has to be contemplated during vaccine design since the accumulation of antigenic 
diversity might impair the outcome of the protective immunization 32. 
Page 26 of 39
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
27
Faced with a complex repertoire of putative gland secreted proteins, it may be beneficial to 
design new vaccines against the most abundant candidate molecules. Since the MEG proteins 
display short sequences, lack conserved protein domains and are likely to possess 
intrinsically disordered structures 33, it is unlikely these molecules exhibit any catalytic 
activity. This led us to hypothesise that their abundance in the parasite esophagus may reflect 
the rate at which these proteins are consumed by interaction with incoming blood. Absolute 
quantification revealed MEG-12 as the most abundant target protein per cell, among the nine 
putative gland secretions evaluated in the QconCAT assay. Specific expression of MEG-12 in 
the anterior esophageal gland of male and female adult worms was confirmed by whole 
mount in-situ hybridization 7, and together these data may suggest it could play an important 
role in the first contact with incoming blood. So far, MEG-12 has been proposed to function 
by interacting with erythrocytes and promoting hemolysis through a predicted amphipatic 
helix 7. VAL-7 and MEG 4 family proteins, all secreted by the posterior gland, also exhibited 
a high number of copies per cell and is reinforced by high expression of the cognate 
transcripts, as already revealed by microarray and quantitative RNAseq 7,29,34. 
The esophageal glands and the syncytial gastrodermis are the major secretory structures in 
the upper and lower alimentary tract, respectively 35. Our results showed that GO terms 
related to secretion via vesicle transport are significantly overrepresented among proteins 
differentially expressed in the ESO proteome when compared with the BE. The remarkable 
expression of molecules tightly related to vesicle-trafficking such as a tetraspanin CD63 
receptor and a non-tegument annexin (Smp_155580), as well as proteins related to 
sphingolipid biosynthesis, might constitute a route for a therapeutic intervention. In 
particular, annexins have been proposed as potential drug and vaccine targets because of their 
important role in secretory processes and exposure to the host immune system 36. Notably, 
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disrupting vesicle release in the esophageal lumen has been implicated in the self-cure 
response of the Rhesus macaque 6.
The highlighted activity of secretory pathways is probably linked to the repertoire of 
glycosyltransferases differentially abundant in the schistosome esophagus. The enrichment of 
proteins linked to N- and O-glycosylation in the ESO sample matches the requirement of a 
specialised machinery for decorating gland products with specific glycan moieties. Notably, 
the enrichment of beta-1,3-galactosyltransferase and GalNAc transferases in the esophageal 
region indicates a favourable environment for production of glycoproteins modified with 
galactosyl (β-1,3) N-acetylgalactosamine, which may explain the strong reactivity of the 
lectin PNA (peanut agglutinin) towards the esophageal glands 37. In previous experiments we 
demonstrated MEG-4.1 as one of the PNA-reactive antigens, based on bidimensional western 
blotting 9. Remarkably, MEG-4.1 reactivity was shown split into two spots, indicating either 
the presence of glycoforms or alternatively spliced sequences. We acknowledge that several 
O-glycosylation sites predicted for MEG-4.1 are located within a tandemly repeated 
sequence. Detection of non-decorated peptides derived from this region suggests that 
glycosylation can be differential. However, the extent of the glycosylation over the repetitive 
sequence cannot be inferred from bottom-up proteomics.  Nevertheless, unceasing production 
of fully glycosylated forms would require constant availability of glycan precursors. This 
condition might not be fulfilled since esophageal MEG proteins are the most rapidly 
synthesised, during in vitro turnover experiments (manuscript in preparation). In future 
investigations it would be beneficial to characterise the extent and type of glycans linked to 
the protein antigens of interest.
Finally, we interrogated our data for proteins known to be present in the worm vomitus 21. 
Although gut secretions dominate these preparations, additional components originated from 
the esophagus, including MEG proteins (manuscript in preparation) and molecules released 
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from the membranocalyx were among the secreted molecules. In this context, our quantitative 
ESO vs BE analysis provided additional information regarding the preferential site of 
expression of many proteins so far attributed to the gastrodermis. Although regurgitation of 
gut content and imprecise dissection might contribute unwanted contamination by 
gastrodermal secretions in the esophageal lumen we didn’t observe any bias suggesting that 
our ESO preparation had significant contamination with abundant gut secretions. Classical 
gut-associated antigens such as Sm31 and Sm32, were highly expressed in the BE, enzymes 
and transporters such as Acyl-CoA thioesterase, beta-D-xylosidase, NPC2, and some 
saposins were shown to be equally abundant in both ESO and BE fragments. This might 
suggest that some hydrolases thought to be exclusive to the gut compartment do in fact 
function in unrelated worm tissues not resolved by the ESO vs BE approach. For instance, 
this might include lipid and cholesterol binding and transport – by saposins and NPC2 – and 
iron binding by ferritin, by lysosomes in other tissue locations. 
Moreover, we highlight that the ESO vs BE comparison provided new information on a group 
of cathepsins. SmCL1, CL2 and CL3 have been reported as specific gastrodermal 
constituents 38,39. However, only SmCL2 was enriched in the BE sample. This might indicate 
that both SmCL1 and SmCL3 exhibit a more promiscuous biological role in other tissues, 
besides blood digestion in the parasite intestine. Differences in the pH optima of these 
enzymes should be considered. Whilst SmCL2 activity is restricted to acidic environments, 
such as that found in the parasite gut lumen, SmCL1 exhibits a broad pH profile (80% at pH 
5-7.2, optimum pH 6.5) 40, similar to SmCL3 39. Therefore, our data suggest SmCL2 as the 
only member among SmCL peptidases, that is solely active in the schistosome gut.
Conclusion
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The schistosome feeding process is multistep and takes place within three chambers, clearly 
demarcated along the alimentary tract, namely the anterior and posterior esophageal lumen 
and the gut proper 35. Unlike the gut, proteomic analysis of esophageal secretions produced 
by the esophageal glands has not previously been attempted since isolation of this 
microproteome is challenging. In this study we developed a dissection technique enabling the 
generation of esophageal fragments for detailed characterisation of the S. mansoni esophagus. 
Our results revealed a complex protein composition in the esophageal region with evidence 
of antigenic variation of MEG-encoded proteins that might have serious implications in 
immune evasion. Nevertheless, the remarkable abundance of esophageal MEG proteins 
suggests a high demand for those constituents in the incessant blood processing cascade. In 
addition, dissection of the esophagus versus the back end provided an overview of differential 
biological processes enriched in the two body fragments, as well as updating the repertoire of 
proteins involved in the later steps of blood digestion and nutrient acquisition. Together, our 
data provide the basis for a better-oriented selection of alimentary tract candidates for vaccine 
development.
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